World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
151
Citations
89918
World Ranking
1116
National Ranking
27

Loïc Guillevin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Loïc Guillevin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,229 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Loïc Guillevin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Loïc Guillevin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 151 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Loïc Guillevin is affiliated with Université Paris Cité in France and has a substantial body of work in medical research, particularly focusing on vasculitis and related conditions. The main field of study includes Medicine, with a strong emphasis on subfields such as Pulmonary and Respiratory Medicine, Rheumatology, Genetics, Immunology, and Physiology.

Their research topics cover a range of specialized areas including:

  • Vasculitis and related conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Eosinophilic Disorders and Syndromes
  • Otitis Media and Relapsing Polychondritis
  • Urticaria and Related Conditions
  • Sarcoidosis and Beryllium Toxicity Research
  • Renal Diseases and Glomerulopathies

Loïc Guillevin has coauthored frequently with several researchers, notably:

  • Benjamin Terrier
  • Xavier Puéchal
  • Luc Mouthon
  • F. Maurier
  • Pascal Cohen

The scientist has published extensively in the following journals and venues:

  • Lara D. Veeken
  • La Revue de Médecine Interne
  • Arthritis & Rheumatology
  • La Presse Médicale
  • Annals of the Rheumatic Diseases

Recent significant papers associated with or relevant to Loïc Guillevin's research interests include:

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, 2020, UNC Libraries
  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis, 2020, New England Journal of Medicine
  • Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis, 2023, Nature Reviews Rheumatology
  • Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2020, Annals of Internal Medicine
  • Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study, 2020, Arthritis & Rheumatology

These publications reflect an ongoing engagement with autoimmune and inflammatory diseases, mainly focusing on vasculitis and eosinophilic granulomatosis, covering both diagnostic criteria and therapeutic approaches.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Churg-Strauss Syndrome. Clinical Study and Long-Term Follow-Up of 96 Patients

    Loïc Guillevin;Pascal Cohen;Martine Gayraud;François Lhote

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

    David R.W. Jayne;Gill Gaskin;Niels Rasmussen;Daniel Abramowicz

  • Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

    Loïc Guillevin;François Lhote;Martine Gayraud;Pascal Cohen

  • Revised international Chapel Hill consensus conference nomenclature of vasculitides

    J. C. Jennette;R. J. Falk;P. Bacon;N Basu

  • Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Microscopic polyangiitis: Clinical and laboratory findings in eighty‐five patients

    Loïc Guillevin;Bernard Durand‐Gasselin;Ramiro Cevallos;Martine Gayraud

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

    Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier

  • The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.

    Loïc Guillevin;Christian Pagnoux;Raphaele Seror;Alfred Mahr

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

    Ronald J. Falk;Wolfgang L. Gross;Loïc Guillevin;Gary S. Hoffman

  • Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

    Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Bernhard Hellmich;Oliver Flossmann;Wolfgang L Gross;Paul Bacon

  • A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

    Loïc Guillevin;Jean-François Cordier;Franïois Lhote;Pascal Cohen

  • Long‐term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg‐Strauss syndrome: Analysis of four prospective trials including 278 patients

    Martine Gayraud;Loïc Guillevin;Philippe Le Toumelin;Pascal Cohen

Frequent Co-Authors

Luc Mouthon
Luc Mouthon Université Paris Cité
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Alfred Mahr
Alfred Mahr Université Paris Cité
Olivier Lortholary
Olivier Lortholary Université Paris Cité
Eric Hachulla
Eric Hachulla University of Lille
David Jayne
David Jayne University of Cambridge
Olivier Fain
Olivier Fain Université Paris Cité
Marc Humbert
Marc Humbert University of Paris-Saclay
Philippe Ravaud
Philippe Ravaud Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring medical careers beyond traditional MD programs, online degrees in nursing and related fields provide flexible options. Many students now pursue nursing qualifications entirely online, allowing them to balance education with work or family responsibilities.

If affordability is a concern, consider the cheapest online dnp programs for advanced nursing practice. These programs help nurses move into leadership or specialist roles without the high cost of traditional tuition.

Registered Nurses looking to advance their credentials can explore rn to bsn cheapest programs, which allow working nurses to earn a bachelor's degree swiftly and affordably online.

For individuals with a non-nursing background, direct entry msn programs online provide a pathway to become a nurse at the master's level, often in a shorter time frame.

Entry-level options also exist through online adn programs for non nurses, allowing those without prior nursing education to quickly begin careers in healthcare.

These online options broaden access to medical careers and can serve as stepping stones for further specialization or advancement in healthcare.

Best Scientists Citing Loïc Guillevin

Trending Scientists

Recently Published Articles